Accelerated Pharma is a clinical-stage pharmaceutical company whose drug development strategy is based on individualized targeting of patients using genomics.
Developing drugs that target RNA-modifying proteins for new cancer therapies.
Adlai Nortye is a biopharmaceutical company discovering, developing and commercializing new drugs for cancer and metabolic diseases.
Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Uses a variety of techniques that include multiplexed PCR and lab automation.
AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need.
Healthcare data analytics via the Cota Nodal Address classification system, which creates patient cohorts by categorizing patient-specific medical histories, information on their diseases, and ...
Develops glutamine antagonists "immune-metabolism" to improve immune responses against cancer tumors.
Basic research, cancer research, immunotherapy. Fred Hutchinson Cancer Research Center is dedicated to the elimination of cancer and related diseases as causes of human suffering and death ...
GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable the development of precision cancer drugs while improving patient outcomes.
Genenta is developing a gene transfer strategy into hematopoietic cells to target a specific anti-tumor protein. A disabled virus vector delivers the gene into the cells. A combination of ...
GenomOncology enables real-time clinical decision-making at the point-of-care for Molecular Pathologists, Clinical Oncologists and Cancer Informaticists in their research of cancer treatments and ...
Hudson Biopharma is currently focused on the discovery of new anticancer drugs and medications.
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).
iTeos Therapeutics is targeting the tumor microenvironment to enhance the effectiveness of T-cells at eradicating cancer
Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on developing new targeted therapies to treat cancer and liver diseases
Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with clinical information incorporate all new discoveries in treatment plans.
Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates
Notable Labs is a drug testing service to help oncologists identify actionable treatment options for people with blood cancers.
Nucleix has developed a method to read DNA Methylation changes.
At Omicsoft, we focus on biomarker data management, visualization, and analysis. In order to achieve our goal of being the leader in next generation sequencing, bioinformatics, and cancer genomics ...
Oncologie is developing next-generation biologics and small molecules. Oncologie's portfolio covers the spectrum of the cancer immunology landscape.
Pediatric brain tumor treatments
OrigiMed is a medical science and technology company that is focused on identifing cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to ...
Develops peptides to stimulate cytotoxic T-Cells.
At PapGene, Inc.is developing tests that uncover early-stage cancers from the analysis of easily accessible body fluids. PapGene has developed a proprietary platform that enables detection of a ...
The backbone of the ARCUS technology is the ARC Nuclease – a fully synthetic enzyme that is very similar to a homing endonuclease but is modified to be a better starting point for the development ...
Rakuten Aspyrian is a privately funded clinical stage biotechnology company developing tumor-targeted precision therapies based on the new platform Photoimmunotherapy (PIT).
RootPath is a Cambridge-based biotechnology company developing a personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy.
Seattle Cancer Care Alliance offers a bold and innovative approach in the prevention, treatment, and cure of cancer. Combining the talents, expertise, and resources of three world-renowned ...
Childhood Cancer Research, Child Health, Behavior and Development, Clinical and Translational Research, Developmental Biology and Regenerative Medicine, Global Infectious Disease Research, ...
Sensei Biotherapeutics is developing cancer immunotherapies.
Silverback Therapeutics is a Seattle-based start-up biotechnology focused on cancer immunotherapy.
Scientists in more than 100 laboratories are conducting innovative research to advance understanding in the biological sciences and improve human health.
Targovax (OSE:TRVX) is a clinical stage company focused on developing and commercializing immune activators to target hard to treat solid tumors. Immuno-oncology is currently one of the fastest ...
Tempus is a technology company that is building the world's largest library of molecular
and clinical data and an operating system to make that data accessible and useful.
Torque, an immuno-oncology company developing Deep Primed™ cell therapies that direct and evoke immune responses in the tumor microenvironment.
ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses.
WindMIL uses bone marrow derived lymphocytes to develop immunotherapies to treat cancer patients.